Invention Grant
- Patent Title: Epigenetic markers for respiratory allergy
-
Application No.: US15578174Application Date: 2016-05-27
-
Publication No.: US10683547B2Publication Date: 2020-06-16
- Inventor: Patrick de Boever , Sabine Langie
- Applicant: VITO NV
- Applicant Address: BE Mol
- Assignee: VITO NV
- Current Assignee: VITO NV
- Current Assignee Address: BE Mol
- Agency: Knobbe, Martens, Olson & Bear LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6e40ecef
- International Application: PCT/EP2016/062017 WO 20160527
- International Announcement: WO2016/193151 WO 20161208
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; C12P19/34
Abstract:
A method relates to epigenetic markers and their diagnostic and predictive value for respiratory allergy. The method can include assaying a test sample from the patient for a DNA hypermethylation or hypomethylation of at least GLI2 region, in which hypermethylation or hypomethylation of the gene region in the test sample indicates or predicts a respiratory allergy in the patient.
Public/Granted literature
- US20180148785A1 EPIGENETIC MARKERS FOR RESPIRATORY ALLERGY Public/Granted day:2018-05-31
Information query
